News

The U.S. Veterans Administration measures a substantial reduction in its carbon footprint associated with patient travel by ...
At the end of 2023, more than one-third of new prescriptions to treat Type 2 diabetes were GLP-1s, such as Mounjaro and Ozempic, among others, according to a study published April 15 in Annals of ...
As demand for GLP-1 medications surges, Hydreight’s inclusion of Liraglutide introduces a stable, patent-free, and clinically proven option—ideal for patients and providers seeking consistent ...
Mobile health technologies, such as wearable devices, mobile health apps and telehealth or remote coaching, have shown potential ...
Mobile health technologies, such as wearable devices, mobile health apps and telehealth or remote coaching, have shown potential to help people start and maintain heart-healthy behaviors, such as ...
Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...
A new study from Texas A&M University shows that online diabetes self-management programs can help people with type 2 ...
The telehealth company is offering Lilly’s branded form of tirzepatide—approved for weight loss—on its site for $1,899 a ...
Five researchers from Deakin's Faculty of Health have been awarded $10.8 million in Medical Research Future Fund (MRFF) grants.
In addition, undergoing the synchronous video telehealth appointments increased participant knowledge of their cat’s mobility challenges and perceived helpfulness of their at-home management ...
The global diabetes care devices market is poised for substantial expansion, with projections indicating a rise from USD 64.5 billion in 2024 to an impressive USD 117.7 billion by 2034. The market’s ...
The keto diet is a potentially helpful way for people with diabetes to manage blood sugar levels. This diet greatly restricts carbohydrates, which impact blood sugar. It may also aid in the reversal ...